.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Mallinckrodt
Teva
Cantor Fitzgerald
Baxter
Healthtrust
Moodys
Cerilliant
Daiichi Sankyo

Generated: July 23, 2017

DrugPatentWatch Database Preview

Zaleplon - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for zaleplon and what is the scope of zaleplon freedom to operate?

Zaleplon
is the generic ingredient in two branded drugs marketed by Cipla Ltd, Upsher-smith Labs, Aurobindo Pharma, West-ward Pharms Int, Mylan, Teva Pharms, Hikma Pharms Llc, Pfizer, Orchid Hlthcare, and Unichem, and is included in eleven NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for zaleplon. Twenty-three suppliers are listed for this compound.

Summary for Generic Name: zaleplon

Tradenames:2
Patents:1
Applicants:10
NDAs:11
Drug Master File Entries: see list12
Suppliers / Packagers: see list23
Bulk Api Vendors: see list50
Clinical Trials: see list16
Patent Applications: see list3,001
Therapeutic Class:Sedatives/Hypnotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:zaleplon at DailyMed

Pharmacology for Ingredient: zaleplon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms Llc
ZALEPLON
zaleplon
CAPSULE;ORAL078147-001Nov 25, 2008ABRXNoNo► Subscribe► Subscribe
Unichem
ZALEPLON
zaleplon
CAPSULE;ORAL078989-001Jun 6, 2008ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
ZALEPLON
zaleplon
CAPSULE;ORAL077237-001Jun 6, 2008ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma
ZALEPLON
zaleplon
CAPSULE;ORAL078829-001Jun 6, 2008ABRXNoNo► Subscribe► Subscribe
Upsher-smith Labs
ZALEPLON
zaleplon
CAPSULE;ORAL078095-001Jun 6, 2008DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: zaleplon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
SONATA
zaleplon
CAPSULE;ORAL020859-001Aug 13, 19994,626,538► Subscribe
Pfizer
SONATA
zaleplon
CAPSULE;ORAL020859-002Aug 13, 19994,626,538► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Moodys
McKinsey
Johnson and Johnson
Fish and Richardson
Julphar
Citi
UBS
US Army
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot